alexa

GET THE APP

The Efficacy Of Bile Acids In The Treatment Of Non-alcoholic Steatohepatitis: A 10-year Systematic Review | 102285
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google scholar citation report
Citations : 1384

Journal of Gastrointestinal & Digestive System received 1384 citations as per google scholar report

Journal of Gastrointestinal & Digestive System peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

The efficacy of bile acids in the treatment of non-alcoholic steatohepatitis: A 10-year systematic review

16th International Conference on Gastroenterology and Digestive Disorders

Higinio T Mappala

Jose Reyes Mem. Medical Center, Philippines

Keynote: J Gastrointest Dig Syst

DOI: 10.4172/2161-069X-C3-069

Abstract
Non-Alcoholic Fatty Liver Disease (NAFLD) is one of the most common forms of chronic liver disease which may progress to Non-Alcoholic Steatohepatitis (NASH). Currently there are no therapeutic strategies for such disease. Only lifestyle modification through diet and exercise were proven to afford some benefit in patients with NAFLD. No pharmacologic agents have so far been approved for the treatment of NAFLD or NASH. Therefore, most clinical efforts have been directed at treating the components of metabolic syndrome, namely obesity, diabetes, hypertension and dyslipidemias. Other interventions are directed at specific pathways potentially involved in the pathogenesis of NAFLD, such as insulin resistance, oxidative stress, proinflammatory cytokines, apoptosis, bacterial overgrowth and angiotensin pathway. This lecture aims to show the potential of bile acids as a promising therapeutic option for NAFLD. This is a 10-year systematic review of the effects of bile acids on Non-Alcoholic Fatty Liver Disease (NAFLD). Bile Acids may yet prove to be an effective targeted treatment for non-alcoholic fatty liver disease.
Biography

Higinio T Mappala is a Medical Specialist IV at the Jose Reyes Memorial Medical Center, Manila, Philippines, a Board-certified Internist, Gastroenterologist, Endoscopist, Clinical Nutritionist and Clinical Toxicologist. He has served as a University Professor and Dean of 2 Medical Schools; a highly-regarded Researcher, with more than 50 scientific papers and more than 20 publications. He is a former Board Director of the Philippine Societies of Gastroenterology and Digestive Endoscopy; an online Research rater of McMaster, Canada and Online Dynamed Research peer-reviewer.

E-mail: [email protected]

 

Top